Skip to main content
English

Suche

  1. Home
  2. Suche

Webseiten-Inhalte

Jan Pencik wins Nature Poster Prize ... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/?L=3
Jan Pencik wins Nature Poster Prize ... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/people-of-the-meduni-vienna/?L=3
Jan Pencik wins Nature Poster Prize ... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/?cHash=c392327d1d79480b30b6774d9fb3de0a&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=13
Jan Pencik wins Nature Poster Prize ... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=13&cHash=c392327d1d79480b30b6774d9fb3de0a
Jan Pencik wins Nature Poster Prize ... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=4&cHash=3a363d7eb3f191914179755d163f94fa
News ... Kenner vom Klinischen Institut für Pathologie der MedUni Wien. Die Wissenschafter nehmen an, dass bei der üblichen Chemotherapie zwar die Krebszellen, die sich im Körper ausbreiten, getötet werden, jedoch nicht die originalen "Krebsstammzellen", von denen der Tumor ursprünglich ausgeht. Lukas Kenner... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/ursache-einer-aggressiven-krebsart-im-kindesalter-identifiziert/?L=3
News ... Kenner vom Klinischen Institut für Pathologie der MedUni Wien. Die Wissenschafter nehmen an, dass bei der üblichen Chemotherapie zwar die Krebszellen, die sich im Körper ausbreiten, getötet werden, jedoch nicht die originalen "Krebsstammzellen", von denen der Tumor ursprünglich ausgeht. Lukas Kenner... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=3219&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=3b4d0528c57007cdb6cdc9967ba6eea2
News ... Kenner vom Klinischen Institut für Pathologie der MedUni Wien. Die Wissenschafter nehmen an, dass bei der üblichen Chemotherapie zwar die Krebszellen, die sich im Körper ausbreiten, getötet werden, jedoch nicht die originalen "Krebsstammzellen", von denen der Tumor ursprünglich ausgeht. Lukas Kenner... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/?tx_news_pi1%5Bnews%5D=3219&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=3b4d0528c57007cdb6cdc9967ba6eea2
Immunmarkeranalyse: Tumorgewebefläche ist entscheidend für Überlebensprognose ... Immunzellgeschehen im Tumor besser ab als gewebssparende, gestanzte Proben. Diese Erkenntnis konnte ein Team um die Chirurgin Elisabeth S. Gruber und den Molekularpathologen Lukas Kenner von der MedUni Wien anhand immunhistochemischer Gewebeanalysen von PatientInnen mit Rektumkarzinom nachweisen. Bei der zweiten... https://www.meduniwien.ac.at/web/index.php?id=6143&L=3
Immunmarkeranalyse: Tumorgewebefläche ist entscheidend für Überlebensprognose ... Immunzellgeschehen im Tumor besser ab als gewebssparende, gestanzte Proben. Diese Erkenntnis konnte ein Team um die Chirurgin Elisabeth S. Gruber und den Molekularpathologen Lukas Kenner von der MedUni Wien anhand immunhistochemischer Gewebeanalysen von PatientInnen mit Rektumkarzinom nachweisen. Bei der zweiten... https://www.meduniwien.ac.at/web/index.php?id=6143&L=3&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=f7b8aacc5325df0b91e534c46b12ab37